FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Yocum

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Double-Blind Method

Anatomy

Physiology

Drug Resistance

Co-author Network

Publications

TOP 3
Ewa Olech; John V Crues; David E Yocum; Joan T Merrill
Bone marrow edema is the most specific finding for rheumatoid arthritis (RA) on noncontrast magnetic resonance imaging of the hands and wrists: a comparison of patients with RA and healthy controls.
Jane E Freeston; Ewa Olech; David E Yocum; Elizabeth M A Hensor; Paul Emery; Philip Conaghan
A modification of the Omeract RA MRI score for erosions for use with an extremity MRI system with reduced field of view.
Joseph Huffstutter; W David Craig; Gregory Schimizzi; John Harshbarger; Jeffrey Lisse; Shelley Kasle; Lisa Hymson; David E Yocum; Lesley Castro; Ronald Hegedus; Peter Callegari; Newman Yeilding; Keith Gilmer
A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Yocum (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Ewa Olech; John V Crues; David E Yocum; Joan T Merrill
Bone marrow edema is the most specific finding for rheumatoid arthritis (RA) on noncontrast magnetic resonance imaging of the hands and wrists: a comparison of patients with RA and healthy controls.
The Journal of rheumatology 2010;37(2):265-74.
2007: Jane E Freeston; Ewa Olech; David E Yocum; Elizabeth M A Hensor; Paul Emery; Philip Conaghan
A modification of the Omeract RA MRI score for erosions for use with an extremity MRI system with reduced field of view.
Annals of the rheumatic diseases 2007;66(12):1669-71.
2007: Joseph Huffstutter; W David Craig; Gregory Schimizzi; John Harshbarger; Jeffrey Lisse; Shelley Kasle; Lisa Hymson; David E Yocum; Lesley Castro; Ronald Hegedus; Peter Callegari; Newman Yeilding; Keith Gilmer
A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis.
Current medical research and opinion 2007;23(8):1967-79.
2007: Daniel E Furst; Norman Gaylis; Vance Bray; Ewa Olech; David E Yocum; Jeffrey Ritter; Michael Weisman; Daniel J Wallace; John V Crues; Dinesh Khanna; Gregory Eckel; Newman Yeilding; Peter Callegari; Sudha Visvanathan; Jeannie Rojas; Ronald Hegedus; Laura George; Khalid Mamun; Keith Gilmer; Orrin Troum
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study.
Annals of the rheumatic diseases 2007;66(7):893-9.
2006: David E Yocum; Philip Conaghan; Ewa Olech; Charles Peterfy
Response: office-based low-field extremity magnetic resonance imaging: is the glass half empty or half full?
Arthritis and rheumatism 2006;54(4):1048-50.
2006: Daniel O Clegg; Domenic Reda; Crystal Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
The New England journal of medicine 2006;354(8):795-808.
2005: Steven A Mazzuca; Kenneth D Brandt; Donald S Schauwecker; Barry P Katz; Joan M Meyer; Kathleen A Lane; John D Bradley; Steven T Hugenberg; Frederick Wolfe; Larry W Moreland; Louis W Heck; David E Yocum; Thomas J Schnitzer; Leena Sharma; Susan Manzi; Chester V Oddis
Severity of joint pain and Kellgren-Lawrence grade at baseline are better predictors of joint space narrowing than bone scintigraphy in obese women with knee osteoarthritis.
The Journal of rheumatology 2005;32(8):1540-6.
2005: Kenneth D Brandt; Steven A Mazzuca; Barry P Katz; Kathleen A Lane; Kenneth A Buckwalter; David E Yocum; Frederick Wolfe; Thomas J Schnitzer; Larry W Moreland; Susan Manzi; John D Bradley; Leena Sharma; Chester V Oddis; Steven T Hugenberg; Louis W Heck
Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial.
Arthritis and rheumatism 2005;52(7):2015-25.
2004: Steven A Mazzuca; Kenneth D Brandt; Barry P Katz; Kathleen A Lane; John D Bradley; Louis W Heck; Steven T Hugenberg; Susan Manzi; Larry W Moreland; Chester V Oddis; Thomas J Schnitzer; Leena Sharma; Frederick Wolfe; David E Yocum
Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug.
Arthritis and rheumatism 2004;51(6):933-40.
2004: David E Yocum; Daniel E Furst; W G Bensen; F X Burch; Mary Ann Borton; Laurel J Mengle-Gaw; Benjamin D Schwartz; W Wisememandle; Qais A Mekki
Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
Rheumatology (Oxford, England) 2004;43(8):992-9.
2004: Xiaolei Tang; David E Yocum; David Dejonghe; Kathy Nordensson; Douglas F. Lake; John Richard
Increased activation-induced cell death in peripheral lymphocytes of rheumatoid arthritis patients: the mechanism of action.
Immunology 2004;112(3):496-505.
2004: Laurie Bergstrom; David E Yocum; Neil M Ampel; Isidro Villanueva; Jeffrey Lisse; Oscar Gluck; John Tesser; James Posever; Margaret Miller; Julio Araujo; Dana M Kageyama; Martin Berry; Linda Karl; Christianne M Yung
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists.
Arthritis and rheumatism 2004;50(6):1959-66.
2004: David E Yocum
Effective use of TNF antagonists.
Arthritis research & therapy 2004;6 Suppl 2():S24-30.
2003: David E Yocum; Daniel E Furst; Jeffrey L Kaine; Andrew R Baldassare; Jon T Stevenson; Mary Ann Borton; Laurel J Mengle-Gaw; Benjamin D Schwartz; Wayne Wisemandle; Qais A Mekki
Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial.
Arthritis and rheumatism 2003;48(12):3328-37.
2003: Samuel F Schluter; Miranda K Adelman; V Taneja; Chella S David; David E Yocum; John J Marchalonis
Natural autoantibodies to TCR public idiotopes: potential roles in immunomodulation.
Cellular and molecular biology (Noisy-le-Grand, France) 2003;49(2):193-207.
2002: Xiaolei Tang; David E Yocum; David DeJonghe; Kathy Nordensson
Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells.
Immunology 2002;107(1):56-68.
2002: Daniel E Furst; Kenneth G Saag; M Roy Fleischmann; Yvonne Sherrer; Joel A Block; Thomas Schnitzer; Joel Rutstein; Andrew Baldassare; Jeffrey L Kaine; Leonard Calabrese; Fredrick Dietz; Marshall Sack; R Gordon Senter; Craig Wiesenhutter; Michael Schiff; C Michael Stein; Yoichi Satoi; Alan K. Matsumoto; Jacques Caldwell; Robert E Harris; Larry W Moreland; Eric Hurd; David E Yocum; David A Stamler
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
Arthritis and rheumatism 2002;46(8):2020-8.
2002: Tino Munster; John P Gibbs; Danny Shen; Bruce Baethge; Gary R Botstein; Jacques Caldwell; Fredrick Dietz; Robert Ettlinger; Harvey E Golden; Herbert B Lindsley; George E McLaughlin; Larry W Moreland; W Neal Roberts; Theodore W Rooney; Bruce Rothschild; Marshall Sack; Anthony I Sebba; Michael Weisman; Kathryn E Welch; David E Yocum; Daniel E Furst
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
Arthritis and rheumatism 2002;46(6):1460-9.
2002: Ian F Robey; Allen B Edmundson; Samuel F Schluter; David E Yocum; John J Marchalonis
Specificity mapping of human anti-T cell receptor monoclonal natural antibodies: defining the properties of epitope recognition promiscuity.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(7):642-52.
2002: Ian F Robey; Samuel F Schluter; Emmanuel T Akporiaye; David E Yocum; John J Marchalonis
Human monoclonal natural autoantibodies against the T-cell receptor inhibit interleukin-2 production in murine T cells.
Immunology 2002;105(4):419-29.
2002: Ursula Mason; Jose Aldrich; Ferdinand Breedveld; Charles B Davis; Michael Elliott; Mildred Jackson; Christian Jorgensen; Edward C Keystone; Robert Levy; John Tesser; Mark Totoritis; Alemseged Truneh; Michael Weisman; Craig Wiesenhutter; David E Yocum; Jin Zhu
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis.
The Journal of rheumatology 2002;29(2):220-9.
2000: David E Yocum; S Allard; S B Cohen; P Emery; R M Flipo; J Goobar; S Jayawardena; C Job-Deslandre; R W Jubb; K Krüger; A Lopes Vaz; B Manger; E Mur; H Nygaard; S M Weiner; F Rainer; M R Sack; M H Schiff; T J Schnitzer; L B Trigg; I Whatmough; AG Schmidt
Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.
Rheumatology (Oxford, England) 2000;39(2):156-64.
2000: David E Yocum; W L Castro; M Cornett
Exercise, education, and behavioral modification as alternative therapy for pain and stress in rheumatic disease.
Rheumatic diseases clinics of North America 2000;26(1):145-59, x-xi.
2000: Ian F Robey; Samuel F Schluter; David E Yocum; John J Marchalonis
Production and characterization of monoclonal IgM autoantibodies specific for the T-cell receptor.
Journal of protein chemistry 2000;19(1):9-21.
2000: John J Marchalonis; Ian F Robey; Samuel F Schluter; David E Yocum
Epitope promiscuity of human monoclonal autoantibodies to T-cell receptor-combining site determinants.
Applied biochemistry and biotechnology 2000;83(1-3):31-49; discussion 49-52, 145-53.
1999: J J Cush; P Tugwell; M Weinblatt; David E Yocum
US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis.
The Journal of rheumatology 1999;26(5):1176-86.
1999: Daniel E Furst; Herbert B Lindsley; B Baethge; G R Botstein; Jacques Caldwell; Fredrick Dietz; Robert Ettlinger; H E Golden; G E McLaughlin; Larry W Moreland; W Neal Roberts; T W Rooney; B Rothschild; Marshall Sack; Anthony I Sebba; Michael Weisman; K E Welch; David E Yocum
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.
Arthritis and rheumatism 1999;42(2):357-65.
1998: David E Yocum; Alan Solinger; John Tesser; Oscar Gluck; M Cornett; F O'Sullivan; Kathy Nordensson; BK Dallaire; C D Shen; J Lipani
Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trial.
The Journal of rheumatology 1998;25(7):1257-62.
1997: C Michael Stein; Theodore Pincus; David E Yocum; P Tugwell; G Wells; Oscar Gluck; G Kraag; H Torley; John Tesser; R McKendry; RH Brooks
Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group.
Arthritis and rheumatism 1997;40(10):1843-51.
1997: Thomas J Schnitzer; David E Yocum; Margaret Michalska; R Balius; M E Snider; A Hays; L M Thurmond; J M Johnston
Subcutaneous administration of CAMPATH-1H: clinical and biological outcomes.
The Journal of rheumatology 1997;24(6):1031-6.